Vitestro

Funding

• 2026-03-10 - Series B - $70M - Vitestro raises $70M Series B to advance autonomous robotic phlebotomy and commercial readiness - source: vitestro.com
• 2024-04-30 - Venture round - $22M - Vitestro secures $22 million (€20 million) for autonomous blood draw device - source: vitestro.com

View funding

Investors

• EIC Fund - Participant - VC - 2 funding events - repeat backer - first seen 2024-04-30 - latest 2026-03-10
• Invest-NL - Participant - Unknown - 2 funding events - repeat backer - first seen 2024-04-30 - latest 2026-03-10
• NYBC Ventures - Lead - VC - 2 funding events - repeat backer - first seen 2024-04-30 - latest 2026-03-10

View investors

Commercial

2 commercial events; 2 commercial orders; latest event 2024-05-21

• 2024-05-21 - Commercial order - Danish hospital pre-orders 3 blood drawing devices in first international deployment for Vitestro - source: vitestro.com
• 2024-04-03 - Commercial order - Vitestro secures order from Result Laboratorium for two blood drawing devices - source: vitestro.com

View commercial

Timeline

• 2024-08-28 - Regulatory - Vitestro achieves CE marking for autonomous blood drawing device - Vitestro announced CE marking for its autonomous blood drawing device under the European Medical Device Regulation. The approval cleared the device for commercial use across the European Union. The company said several devices had already been ordered and… - source: vitestro.com
• 2024-05-21 - Commercial Order - Danish hospital pre-orders 3 blood drawing devices in first international deployment for Vitestro - Odense University Hospital signed a pre-order for three Vitestro autonomous blood-drawing devices, marking Vitestro's first international customer commitment. The hospital planned to introduce the systems after CE marking, with pre-deployment workflow… - source: vitestro.com
• 2024-04-03 - Commercial Order - Vitestro secures order from Result Laboratorium for two blood drawing devices - Result Laboratorium ordered two Vitestro autonomous blood-drawing devices for its Dutch diagnostic laboratory network. The devices combine AI-guided ultrasound with submillimetre needle positioning and automate the blood-draw workflow through bandaging.… - source: vitestro.com

View timeline

Team

• Toon Overbeeke - CEO & Co-founder - Leads Vitestro?s autonomous robotic phlebotomy device business and clinical adoption strategy.
• Brian Joseph - VP of Product Vision & Co-founder - Shapes Vitestro?s product direction for autonomous blood collection workflows.
• Bob Gerberich - Chief Commercial Officer - Leads Vitestro?s pre-launch market development and commercial execution across European and U.S. healthcare markets.

View team

Relations

• Odense University Hospital - Autonomous Blood Drawing Customer - Odense University Hospital pre-ordered three Vitestro autonomous blood-drawing devices.

View relations

Deployments

• Customer Bound Device Count - 3 autonomous blood-drawing devices pre-ordered - 2024-05-21 - Odense University Hospital - autonomous blood drawing - Odense University Hospital signed a pre-order for three Vitestro autonomous blood-drawing devices, described by Vitestro as its first… - source: vitestro.com

View deployments

Operations

• Production Milestone - 1 source-backed production milestone - 2024-08-28 - Vitestro achieves CE marking for autonomous blood drawing device - source posture: Company Disclosed - source: vitestro.com

View operations